Premium
Prognostic significance of promoter CpG island methylation of obesity‐related genes in patients with nonmetastatic renal cell carcinoma
Author(s) -
MendozaPérez Julia,
Gu Jian,
Herrera Luis A.,
Tannir Nizar M.,
Zhang Shanyu,
Matin Surena,
Karam Jose A.,
Wood Christopher G.,
Wu Xifeng
Publication year - 2017
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/cncr.30707
Subject(s) - medicine , renal cell carcinoma , methylation , cpg site , dna methylation , gene , obesity , oncology , cancer research , promoter , carcinoma , gene expression , genetics , biology
BACKGROUND Greater than 40% of renal cell carcinoma (RCC) cases in the United States are attributed to excessive body weight. Moreover, obesity also may be linked to RCC prognosis. However, the molecular mechanisms underlying these associations are unclear. In the current study, the authors evaluated the role of promoter methylation in obesity‐related genes in RCC tumorigenesis and disease recurrence. METHODS Paired tumors (TU) and normal adjacent (N‐Adj) tissues from 240 newly diagnosed and previously untreated white patients with RCC were examined. For the discovery phase, 63 RCC pairs were analyzed. An additional 177 RCC pairs were evaluated for validation. Pyrosequencing was used to determine CpG methylation in 20 candidate obesity‐related genes. An independent data set from The Cancer Genome Atlas also was analyzed for functional validation. The association between methylation and disease recurrence was analyzed using multivariate Cox proportional hazards models and Kaplan‐Meier survival analysis. RESULTS Methylation in neuropeptide Y ( NPY ), leptin ( LEP ), and leptin receptor ( LEPR ) was significantly higher in TU compared with N‐Adj tissues ( P <.0001) in both the discovery and validation groups. High methylation in LEPR was associated with an increased risk of disease recurrence (hazard ratio, 3.15; 95% confidence interval, 1.23‐8.07 [ P = .02]). Patients with high methylation in LEPR had a shorter recurrence‐free survival compared with patients in the low‐methylation group (log‐rank P = 2.25 × 10 −3 ). In addition, high LEPR methylation in TU was associated with more advanced features ( P ≤.05). Consistent with the findings of the current study, lower LEPR expression in TU compared with N‐Adj tissues ( P = 1.00 × 10 −3 ) was found in data from The Cancer Genome Atlas. CONCLUSIONS Somatic alterations of promoter methylation in the NPY , LEP , and LEPR genes are involved in RCC tumorigenesis. Furthermore, LEPR methylation appears to be associated with RCC recurrence. Future research to elucidate the biology underlying this association is warranted. Cancer 2017;123:3617‐27. © 2017 American Cancer Society .